- LBT Innovations (LBT) has posted its Q3 FY21 report, announcing it’s closing in on appointing a U.S. distributor for APAS Independence technology
- The healthcare stock’s joint venture business, Clever Culture Systems (CCS), is progressing the appointments with a distributor expected to signed by the end of the October quarter
- In terms of sales, LBT said COVID-19 continues to impact its ability to facilitate sales due to travel restrictions and some hospitals remaining closed to guests
- LBT ended March 31 well-funded with $11.3 million in the bank, enough cash to keep the company going for another 94.7 quarters
- The business has also begun the process of rejuvenating its board, with recruitment underway to find a new chair and non-executive director
- Shares in LBT Innovations are trading down 3.41 per cent at 8.5 cents per share
